Page last updated: 2024-11-07

n-acetylthreonine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-acetyl-L-threonine : A N-acetyl-L-amino acid that is the N-acetyl derivative of L-threonine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID152204
CHEBI ID45826
SCHEMBL ID232441
MeSH IDM0174724

Synonyms (28)

Synonym
n-acetylthreonine ,
(2s,3r)-2-acetamido-3-hydroxybutanoic acid
AKOS006345008
acetyl-l-threonine
17093-74-2
unii-v0e98v3r9o
l-threonine, n-acetyl-
v0e98v3r9o ,
n-acetyl-l-threonine
threonine, n-acetyl-, l-
s-(+)-n-acetylthreonine
SCHEMBL232441
ac-thr-oh
AM82242
CHEBI:45826
(2s,3r)-2-acetamido-3-hydroxy-butyric acid
DTXSID80168975
mfcd00037810
ac-thr-oh, aldrichcpr
J-010668
ammonium n-acetyl-l-threoninate
methylammonium n-acetyl-l-threoninate
n-methylcarbonylthreonine
Q27104560
n-acetyl-threonine; lc-tdda; ce10
(2s,3r)-2-acetamido-3-hydroxybutanoicacid
EN300-2991228
CS-0448461

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" No mortalities or evidence of adverse effects were observed in Sprague-Dawley (SD) rats following acute oral administration of 2000 mg of NAT/kg of body weight (kg of bw)."( Safety assessment of N-acetyl-L-threonine.
Barnett, JF; Delaney, BF; Krsmanovic, L; Myhre, A; Shen, ZA; van de Mortel, EL, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
N-acetyl-L-amino acidAn L-amino acid having an N-acetyl substituent.
L-threonine derivativeA proteinogenic amino acid derivative resulting from reaction of L-threonine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-threonine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.78 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]